Eric Archimbaud

7.7k citations
140 papers · 6.6k · 2 hit papers · h-index 37

Impact in

  • Hematology top 0.1%
    • Acute Myeloid Leukemia Research
    • Hematopoietic Stem Cell Transplantation
    • Chronic Myeloid Leukemia Treatments
  • Biochemistry top 1%
    • Antioxidant Activity and Oxidative Stress

Papers in

  • Hematology 99
    • Acute Myeloid Leukemia Research 81
    • Hematopoietic Stem Cell Transplantation 28
    • Multiple Myeloma Research and Treatments 10
    • Chronic Myeloid Leukemia Treatments 10
  • Oncology 40
    • Neutropenia and Cancer Infections 23
Co-authors
Denis M. Fiere (62 shared papers)Lydia Campos (19 shared papers)Xavier Thomas (35 shared papers)Denis Guyotat (23 shared papers)Pierre Fenaux (16 shared papers)Christian Vasselon (3 shared papers)Odile Sabido (4 shared papers)Nora Roubi (3 shared papers)
Journals
Blood (25 papers)British Journal of Haematology (9 papers)Annals of Hematology (9 papers)Leukemia Research (6 papers)Leukemia (5 papers)
Partner nations
FranceUnited StatesItaly

In The Last Decade

Eric Archimbaud

138 papers receiving 6.2k citations

Eric Archimbaud's Hit Papers

A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance Therapy in Newly Diagnosed Acute Promyelocytic Leukemia 1999 · 644 citations
6440+11+22Years since publication200400600
What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

  1. 1999 Blood
  2. 1993 Blood

Peers

Eric Archimbaud
Comparison fields: 5 of 108
  • Hematology 4.3k
  • Biochemistry 410
  • Genetics 633
  • Oncology 1.4k
  • Public Health, Environmental and Occupational Health 1.3k
Replace R Ohno with:
R Ohno Japan
Francesco Fabbiano Italy
Claude Gardin France
Juan Bergua Spain
Pierre W. Wijermans Netherlands
Petra Muus Netherlands
David R. Head United States
Sylvie Castaigné France
Javier de la Serna Spain
Sally B. Killick United Kingdom
Eric Archimbaud relative to R Ohno Japan R Ohno's profile →
Citations per field
00.5×1.5×2.0×
R Ohno · 1×
Citations per year

Countries citing papers authored by Eric Archimbaud

Since Specialization
Citations

This map shows the geographic impact of Eric Archimbaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Archimbaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Archimbaud more than expected).

Fields of papers citing papers by Eric Archimbaud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Archimbaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Archimbaud. The network helps show where Eric Archimbaud may publish in the future.

Co-authors

The 25 scholars most cited alongside Eric Archimbaud, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eric Archimbaud Line = papers co-authored together Eric Archimbaud links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 140 papers — load more, or switch the sort, to bring in the rest.

#Work
1
High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy
Blood ·Lydia Campos, JP Rouault, Odile Sabido, P. Oriol, Nora Roubi, Christian Vasselon, Eric Archimbaud, JP Magaud
Hit paper breakdown →		1993684
2
A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance Therapy in Newly Diagnosed Acute Promyelocytic Leukemia
Blood ·Pierre Fenaux, Claude Chastang, Sylvie Chevret, Miguel Ángel Sanz, Hervé Dombret, Eric Archimbaud, Martin F. Fey, Consuelo Rayón
Hit paper breakdown →		1999644
3
Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis [see comments]
Blood ·Lydia Campos, Denis Guyotat, Eric Archimbaud, P Calmard-Oriol, T Tsuruo, Jacques Troncy, Danielle Treille, Denis M. Fiere
1992442
4
Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group
Blood ·Pierre Fenaux, M-C. Le Deley, Sylvie Castaigné, Eric Archimbaud, Christine Chomienne, Hartmut Link, A. Guerci, María Camila Pérez Duarte
1993439
5
Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group.
Journal of Clinical Oncology ·Bob Löwenberg, Stefan Suciu, Eric Archimbaud, H. L. Haak, Pierre A. Stryckmans, Ralph Cataldo, A. W. Dekker, Zwi Nisan Berneman
1998247
6
Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle Osseuse [see comments]
Blood ·Didier Blaise, Dominique Maraninchi, Eric Archimbaud, JOSY REIFFERS, A Devergié, J.P. Jouet, Noel Jean Milpied, Michel Attal
1992205
7
All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 cases
Blood ·Pierre Fenaux, Sylvie Castaigné, Hervé Dombret, Eric Archimbaud, María Camila Pérez Duarte, Pierre Morel, Thierry Lamy, H Tilly
1992201
8
Use of recombinant GM-CSF during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia: final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the Research and Treatment of Cancer and the Dutch Belgian Hemato-Oncology Cooperative Group.
Blood ·Bob Löwenberg, Stefan Suciu, Eric Archimbaud, G.J. Ossenkoppele, G. Verhoef, Edo Vellenga, P. Wijermans, Zwi Nisan Berneman
1997186
9
Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle Osseuse [see comments]
Blood ·Didier Blaise, Dominique Maraninchi, Eric Archimbaud, JOSY REIFFERS, A Devergié, J P Jouet, Noel Jean Milpied, Michel Attal
1992169
10
Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature.
Journal of Clinical Oncology ·Bruno Quesnel, Hagop M. Kantarjian, J P Bjergaard, Ph. Brault, Elihu H. Estey, Jean Luc Laı̈, H Tilly, Anne Marie Stoppa
1993149
11
Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Société Française de Greffe de Moelle (SFGM)
Bone Marrow Transplantation ·Mauricette Michallet, X. Thomas, Vernant Jp, Mathieu Kuentz, Gèrard Socié, H Espérou-Bourdeau, Noel Jean Milpied, Didier Blaise
2000147
12
Surface marker expression in adult acute myeloid leukaemia: correlations with initial characteristics, morphology and response to therapy
British Journal of Haematology ·Lydia Campos, Denis Guyotat, Eric Archimbaud, Yves Devaux, Danielle Treille, Alain Larese, Jean Maupas, Odile Gentilhomme
1989127
13
Rearrangement of CCND1 (BCL1/PRAD1) 3' untranslated region in mantle- cell lymphomas and t(11q13)-associated leukemias
Blood ·Ruth Rimokh, F Berger, Christian Bastard, Benjamin Klein, Martine French, Eric Archimbaud, JP Rouault, B Santa Lucia
1994117
14
Post-transplant obstructive lung disease ("bronchiolitis obliterans"): a clinical comparative study of bone marrow and lung transplant patients
European Respiratory Journal ·François Philit, T Wiesendanger, Eric Archimbaud, Jf Mornex, J Brune, J.-F. Cordier
1995106
15
Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly: confirmation of the existence of different entities with 11q23 breakpoint
Leukemia ·Eric Archimbaud, Christiane Charrin, J.P. Magaud, Lydia Campos, Xavier Thomas, Denis M. Fiere, Ruth Rimokh
1998102
16
Timed sequential chemotherapy for previously treated patients with acute myeloid leukemia: long-term follow-up of the etoposide, mitoxantrone, and cytarabine-86 trial.
Journal of Clinical Oncology ·Eric Archimbaud, Xavier Thomas, V. Leblond, M Michallet, Pierre Fenaux, Catherine Cordonnier, François Dreyfus, Xavier Troussard
199595
17
A Randomized, Double-Blind, Placebo-Controlled Study With Pegylated Recombinant Human Megakaryocyte Growth and Development Factor (PEG-rHuMGDF) as an Adjunct to Chemotherapy for Adults With De Novo Acute Myeloid Leukemia
Blood ·Eric Archimbaud, Oliver Gerhard Ottmann, John A. Liu Yin, Klaus Lechner, Hervé Dombret, Miguel Ángel Sanz, Gerhard Heil, Pierre Fenaux
199991
18
Transplantation with selected autologous peripheral blood CD34+Thy1+ hematopoietic stem cells (HSCs) in multiple myeloma
Experimental Hematology ·Mauricette Michallet, Thierry O. Philip, Irène Philip, Hubert Godinot, Catherine Sebban, Gilles Salles, Anne Thiébaut, Pierre Biron
200088
19
Effectiveness and pharmacokinetics of low-dose all-trans retinoic acid (25 mg/m2) in acute promyelocytic leukemia
Blood ·Sylvie Castaigné, Philippe Lefèbvre, Christine Chomienne, Etienne Suc, Françoise Huguet, Claude Gardin, Alain Jacques Delmer, Eric Archimbaud
199386
20
A chromosome 12 coding region is juxtaposed to the MYC protooncogene locus in a t(8; 12)(q24;q22) translocation in a case of B‐cell chronic lymphocytic leukemia
Genes Chromosomes and Cancer ·Ruth Rimokh, Jean‐Pierre Rouault, Kamal Wahbi, Mylène Gadoux, Marina Lafage, Eric Archimbaud, Christiane Charrin, Odile Gentilhomme
199183

About Eric Archimbaud

Eric Archimbaud is a scholar working on Hematology, Oncology, Genetics, Public Health, Environmental and Occupational Health and Immunology, having authored 140 papers that have together received 6.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (81 papers), Hematopoietic Stem Cell Transplantation (28 papers), Neutropenia and Cancer Infections (23 papers), Acute Lymphoblastic Leukemia research (23 papers), Retinoids in leukemia and cellular processes (21 papers), Chronic Lymphocytic Leukemia Research (17 papers), Multiple Myeloma Research and Treatments (10 papers) and Chronic Myeloid Leukemia Treatments (10 papers). The work is most often cited by research in Hematology (4.3k citations), Biochemistry (410 citations), Genetics (633 citations), Oncology (1.4k citations) and Public Health, Environmental and Occupational Health (1.3k citations). Eric Archimbaud has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Denis M. Fiere, Lydia Campos, Xavier Thomas, Denis Guyotat, Pierre Fenaux, Christian Vasselon, Odile Sabido, Nora Roubi, Sylvie Castaigné and P. Oriol. Their work appears in journals such as Blood, British Journal of Haematology, Annals of Hematology, Leukemia Research and Leukemia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R OhnoBreakdown of academic impact, for papers by Francesco FabbianoBreakdown of academic impact, for papers by Claude GardinBreakdown of academic impact, for papers by Juan BerguaBreakdown of academic impact, for papers by Pierre W. WijermansBreakdown of academic impact, for papers by Petra MuusBreakdown of academic impact, for papers by David R. HeadBreakdown of academic impact, for papers by Sylvie CastaignéBreakdown of academic impact, for papers by Javier de la SernaBreakdown of academic impact, for papers by Sally B. Killick